Timothy P Clackson's Net Worth

$9.61 Million

Estimate Recalculated Sep 18, 2024 03:17PM EST

Who is Timothy P Clackson?

Timothy P Clackson has an estimated net worth of $9.61 Million. This is based on reported shares across multiple companies, which include Theseus Pharmaceuticals, Inc., Forma Therapeutics Holdings, Inc.,, Spring Bank Pharmaceuticals, Inc., Xilio Therapeutics, Inc., Elevation Oncology, Inc., and ARIAD PHARMACEUTICALS INC.

SEC CIK

Timothy P Clackson's CIK is 0001242992

Past Insider Trading and Trends

2012 was Timothy P Clackson's most active year for acquiring shares with 19 total transactions. Timothy P Clackson's most active month to acquire stocks was the month of February. 2012 was Timothy P Clackson's most active year for disposing of shares, totalling 29 transactions. Timothy P Clackson's most active month to dispose stocks was the month of February. 2016 saw Timothy P Clackson paying a total of $895,100.36 for 397,912 shares, this is the most they've acquired in one year. In 2015 Timothy P Clackson cashed out on 390,651 shares for a total of $2,068,072.66, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Theseus Pharmaceuticals, Inc. (THRX) No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 17
Form 4
+0.72%
2.5K
$6.80
$16,995.00
351.03K
Nov 11
Form 4
—
0
—
—
0
Feb 18
Form 4
+0.75%
2.6K
$9.76
$25,381.46
348.53K
Dec 21
Form 3
—
0
—
—
0
No matching records found

Forma Therapeutics Holdings, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-30.84K
—
—
0
Oct 14
Form 4
+17.08%
4.5K
—
—
30.84K
Jun 8
Form 4
+11.66%
2.75K
—
—
26.34K
Jun 17
Form 4
-32.73%
-11.48K
—
—
23.59K
Jun 23
Form 4
—
0
—
—
0
Jun 18
Form 3
—
0
—
—
0
No matching records found

Spring Bank Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.94%
9.42K
—
—
50.49K
Sep 30
Form 4
+26.44%
8.59K
—
—
41.06K
Jun 30
Form 4
—
0
—
—
0
Jun 24
Form 4
+71.82%
13.57K
—
—
32.48K
Mar 31
Form 4
+73.24%
7.99K
—
—
18.9K
Dec 31
Form 4
+50.69%
3.67K
—
—
10.91K
Sep 30
Form 4
—
0
—
—
0
Jul 10
Form 4
+89.58%
3.42K
—
—
7.24K
Jun 28
Form 4
+46.04%
1.2K
—
—
3.82K
Mar 29
Form 4
+70.69%
1.08K
—
—
2.62K
Jan 2
Form 4
+105.91%
788
—
—
1.53K
Oct 1
Form 4
∞
744
—
—
744
Jul 2
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Elevation Oncology, Inc. (ELEV) Snapshot price: $0.6896

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
-100.00%
-15.78K
—
—
0
Sep 1
Form 4
—
0
—
—
0
Jun 16
Form 4
-66.67%
-31.55K
—
—
15.78K
May 31 - Jun 17
Form 3
—
0
—
—
0
No matching records found